439 reports of this reaction
3.1% of all LIDOCAINE HYDROCHLORIDE ANHYDROUS reports
#3 most reported adverse reaction
DRUG INEFFECTIVE is the #3 most commonly reported adverse reaction for LIDOCAINE HYDROCHLORIDE ANHYDROUS, manufactured by Spectra Medical Devices, LLC. There are 439 FDA adverse event reports linking LIDOCAINE HYDROCHLORIDE ANHYDROUS to DRUG INEFFECTIVE. This represents approximately 3.1% of all 13,967 adverse event reports for this drug.
Patients taking LIDOCAINE HYDROCHLORIDE ANHYDROUS who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is moderately reported among LIDOCAINE HYDROCHLORIDE ANHYDROUS users, representing a notable but not dominant share of adverse events.
In addition to drug ineffective, the following adverse reactions have been reported for LIDOCAINE HYDROCHLORIDE ANHYDROUS:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 439 FDA reports for LIDOCAINE HYDROCHLORIDE ANHYDROUS. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 3.1% of all adverse event reports for LIDOCAINE HYDROCHLORIDE ANHYDROUS, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking LIDOCAINE HYDROCHLORIDE ANHYDROUS, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.